pharmaphorum

MAY 4, 2021

COVID-19 has massively accelerated the uptake of digital health technology across the whole ecosystem, with important implications for pharma, medical device and insurance tech companies. In the white paper, expert contributors share a detailed picture of the digital trends with the greatest potential to impact the near future.

Insurance 98

Insurance 98

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Insurance may not cover these without showing clinical event reductions, and I am concerned that it may take five to 10 years to show this for just obesity,” Lavie added. Access to anti-obesity medications.

Labelling 105

Labelling Insurance Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Insurance may not cover these without showing clinical event reductions, and I am concerned that it may take five to 10 years to show this for just obesity,” Lavie added. Access to anti-obesity medications.

Labelling 98

Labelling Insurance Communication FDA 98

PharmaShots

FEBRUARY 14, 2023

Similarly, insurance companies generally cover approved drugs based on efficacy. Whitney Stewart: Our joint white paper with DTA was intentionally made regional-agnostic and is intended to apply across the globe. In this case, the FDA has the framework to evaluate that evidence and confidently provide an outcome.

FDA 40

FDA Communication Insurance 40

PharmaShots

FEBRUARY 14, 2023

Similarly, insurance companies generally cover approved drugs based on efficacy. Whitney Stewart: Our joint white paper with DTA was intentionally made regional-agnostic and is intended to apply across the globe. In this case, the FDA has the framework to evaluate that evidence and confidently provide an outcome.

FDA 40

FDA Communication Insurance 40

Fuld

APRIL 24, 2022

Top traditional banks such as Bank Of America and JP Morgan have already slated cryptocurrencies as a threat , and PwC, in its 2020 Global FinTech Survey , finds that around 28% of banking and payment businesses, and 22% of insurance, wealth, and asset management companies are facing disruption from FinTech.

Grocery Stores 52

Grocery Stores Insurance 52

Pharmaceutical Technology

FEBRUARY 7, 2023

Launching a new drug can be a risky business, with regulatory approval no guarantee that private, commercial, and government-funded insurers will reimburse it. In Europe, the pricing and reimbursement (P&R) of pharmaceuticals is governed by individual member states.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Communication 52